‌Chorea is a movement disorder that stems from something wrong with the basal ganglia nerve structure deep in your brain. It causes involuntary movements of the hands, feet, and face. These movements ...

Chorea is a movement disorder that causes involuntary, unpredictable body movements. Symptoms may include fidgeting to severe uncontrolled arm and leg movements. Chorea is a movement disorder that ...

Chorea is an involuntary movement disorder that causes irregular muscle movements. It occurs due to the overactivity of dopamine in the brain, which can have many causes. Treatment and outlook both ...

Dyskinesia is a state in which someone experiences involuntary movements. Chorea is a type of dyskinesia. Other types of dyskinesia include tics, myoclonus, dystonia, and akathisia. There are ...

Dyskinesia is when you experience involuntary movements. Chorea is one type of dyskinesia. It is associated with health conditions like Huntington’s disease, infection, or side effects of medications.

People with movement disorders can have a difficult time doing day-to-day activities, which could impact their independence. This can affect how people see themselves and affect their social life.

Huntington's disease, formerly known as "St. Vitus' dance," is a rare and incurable brain disorder characterized by movement ...

VANCOUVER — Deutetrabenazine used to treat chorea in patients with Huntington's disease (HD) continues to be safe over the long term, with stabilization of motor symptoms at 1 year, results of a new ...

This page lists all known medications that could potentially lead to 'Chorea' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

A case report indicates that valbenazine may be an effective therapy for chorea-ballism associated with tardive dyskinesia. Valbenazine has therapeutic potential to improve chorea-ballism associated ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile, tolerability and sustained ...

SAN DIEGO, March 17, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from the KINECT ®-HD study showcasing significant improvements in chorea across body regions with ...